Merck, Inc.

🇵🇭Philippines

Country: 🇵🇭Philippines

Ownership: Subsidiary

Employees: -

Market Cap: $295.3B

Website: http://www.merck.ph

Clinical Trials

The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 80

Registration Number: NCT00002387

Locations: 🇺🇸
San Francisco Gen Hosp, San Francisco, California, United States
🇺🇸
Brown Univ / Miriam Hosp, Providence, Rhode Island, United States
🇺🇸
Rush Med Ctr / Section of Infectious Diseases, Chicago, Illinois, United States

and more 5 locations

Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 30

Registration Number: NCT00002361

Locations: 🇺🇸
Northwestern Univ / Div of Infect Diseases, Chicago, Illinois, United States
🇺🇸
Chase Braxton Health Service, Baltimore, Maryland, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States

and more 5 locations

A Study of L-735,524 in HIV-Positive Children and Adolescents

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 12

Registration Number: NCT00002351

Locations: 🇺🇸
Merck & Co Inc, Whitehouse Station, New Jersey, United States

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Phase 2

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 8

Registration Number: NCT00002451

Locations: 🇺🇸
Albany Med College, Albany, New York, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
SUNY at Stony Brook / Division of Infectious Diseases, Stony Brook, New York, United States

A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 540

Registration Number: NCT00002354

Locations: 🇺🇸
Merck & Co Inc, Whitehouse Station, New Jersey, United States

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Phase 3

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 120

Registration Number: NCT00002220

Locations: 🇺🇸
Hawaii AIDS Clinical Trial Unit, Honolulu, Hawaii, United States
🇺🇸
LAC / USC Med Ctr / Infectious Diseases, Los Angeles, California, United States
🇺🇸
Med Ctr of Delaware, Wilmington, Delaware, United States

and more 8 locations

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Phase 4

Completed

Conditions: HIV Infections
Hemophilia A

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 55

Registration Number: NCT00002386

Locations: 🇺🇸
Riley Hosp for Children, Indianapolis, Indiana, United States
🇺🇸
Georgetown U Med Ctr / Div of Hematology / Oncology, Washington, District of Columbia, United States
🇺🇸
Emory Univ, Atlanta, Georgia, United States

and more 5 locations

A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 220

Registration Number: NCT00002430

Locations: 🇺🇸
Emory Univ, Atlanta, Georgia, United States
🇺🇸
Tower ID Med Associates, Los Angeles, California, United States
🇺🇸
AIDS Community Research Consortium, Redwood City, California, United States

and more 43 locations

A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine

Phase 2

Suspended

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 186

Registration Number: NCT00002424

Locations: 🇺🇸
UCLA School of Medicine / Ctr for Research and Education, Los Angeles, California, United States
🇺🇸
Associates in Research, Fort Myers, Florida, United States
🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States

and more 13 locations

A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 27

Registration Number: NCT00000628

Locations: 🇺🇸
Northwestern Univ Med School, Chicago, Illinois, United States
🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
🇺🇸
San Francisco Gen Hosp, San Francisco, California, United States

and more 2 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy